3542 results for «2167»

Filter By

3542 results

TAVI and access: alternating is wise

16 Jan 2024 – From GulfPCR-GIM 2023

Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...

TAVI and access: alternating is wise

Newer generation self-expanding platform: technical optimisation for common clinical challenges

05 Dec 2023 – From GulfPCR-GIM 2023

The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...

Newer generation self-expanding platform: technical optimisation for common clinical challenges

Essentials of lifetime management of TAVR patients using novel Myval THV

05 Dec 2023 – From GulfPCR-GIM 2023

Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...

Essentials of lifetime management of TAVR patients using novel Myval THV

Evidence gap and new indications

05 Dec 2023 – From GulfPCR-GIM 2023

Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...

Evidence gap and new indications

Valve-in-valve: not as simple as it looks

05 Dec 2023 – From GulfPCR-GIM 2023

Thanks to this session, you will enhance your comprehension of anticipating, planning, and executing TAV-in-TAV procedures, and gain insights into preventing coronary obstruction during these interventions.

Valve-in-valve: not as simple as it looks

From access to annulus: overcoming challenging anatomies

05 Dec 2023 – From GulfPCR-GIM 2023

Gain expertise in selecting the appropriate TAVI device for achieving stable deployment in a 90-degree horizontal aorta. Discover techniques for ensuring smooth deliverability, particularly when navigating through tight and tortuous anatomies. Additionally, learn strategies to prepare for future coronary access, irrespective of the height of the...

From access to annulus: overcoming challenging anatomies

TAVI step by step

19 Nov 2023 – From PCR London Valves 2023

Watch this interactive session to get tips and tricks to solve the technical difficulties that can come up during a TAVI, and learn more about mastering CT imaging for successful TAVI planning, understanding valve selection principles, and refining TAVI procedures for improved efficiency and technique.

TAVI step by step

Tailored approaches to complex bifurcation PCI: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

This session focuses on PCI approaches to complex bifurcation. Learn more about the use of TAP technique, provisional stenting in a trifurcation, and complex multivessel PCI through the lens of a selection of cases.

Challenging TAVI cases

19 Nov 2023 – From PCR London Valves 2023

This PCR London Valves 2023 session aims to analyse some of the complex aspects of TAVI by looking at challenging clinical and anatomical scenarios to enable you to learn how to manage potential complications by learning about innovative strategies and exploring different approaches.

Challenging TAVI cases

Challenging CTO interventions: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

Discover challenging CTO interventions and how to resolve them. Examine a variety of techniques used to manage a lesion that is only crossable by wire, and witness the use of extreme measures to overcome an uncrossable CTO lesion.

Planning and execution of re-do TAVI (TAV-in-TAV) procedures

19 Nov 2023 – From PCR London Valves 2023

Redo TAVI poses challenges but can be managed with a step-by-step procedural plan, ensuring better acute and long-term outcomes. Guidelines and industry resources aid in planning, yet forthcoming registry studies are essential for further data and insights. Watch this session to find out more!

Planning and execution of re-do TAVI (TAV-in-TAV) procedures

How to treat my patient with primary mitral regurgitation?

20 Nov 2023 – From PCR London Valves 2023

In this session, study the different cases of primary mitral regurgitation in detail, with diagrams, videos and even recommendations, to find out when to opt for replacement rather than repair, how to better manage transcatheter mitral replacement, and how to get to grips with endoscopic mitral...

How to treat my patient with primary mitral regurgitation?

Abstracts session 1

06 Dec 2023 – From GulfPCR-GIM 2023

Broaden your knowledge with this selection of abstracts submitted to GulfPCR-GIM 2023, covering topics such as aortic procedures, LV function recovery after CTO recanalization, and the state of PCI in the region of Kurdistan in Iraq.

How to treat my patient with combined aortic and mitral valve disease

20 Nov 2023 – From PCR London Valves 2023

Explore this session to gain insights into diverse treatment options for combined heart valve disease. Examine the distinctions between surgical and transcatheter approaches, understanding their nuances, the sequential order of treatment and technical considerations crucial for transcatheter interventions.

How to treat my patient with combined aortic and mitral valve disease

20 years of TEER: a journey at the crossroads of the human heart

20 Nov 2023 – From PCR London Valves 2023

In 2023, with 200,000 MitraClips performed, the session concluded by posing the question of how many M-TEERs would be conducted by 2026. While the answer remains a mystery until PCR LV 2026, explore the fascinating history of transcatheter edge-to-edge mitral valve repair in this session. Delve...

20 years of TEER: a journey at the crossroads of the human heart

Challenging STEMI scenarios: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

Explore a selection of case studies focusing on challenging STEMI scenarios, such as an inferior STEMI with a large thrombus burden, management of coronary dissection in a patient with ectatic coronary artery, and an unusual case of an RCA with an anomalous origin. 

Transcatheter tricuspid edge-to-edge repair step-by-step

21 Nov 2023 – From PCR London Valves 2023

In this interactive session, the comprehensive case of an 81-year-old patient with atrial fibrillation, coronary artery disease and chronic kidney disease, presenting with fatigue, shortness of breath and peripheral oedema, is dissected, allowing meticulous analysis of each step of transcatheter edge-to-edge tricuspid valve repair. Don't miss...

Transcatheter tricuspid edge-to-edge repair step-by-step

How to treat my patient with combined mitral and tricuspid valve disease

21 Nov 2023 – From PCR London Valves 2023

Follow the discussion around the case of this 77-year-old patient with hypertension, diabetes, dyslipidemia, already on dialysis twice a week for chronic kidney disease, and with an implantable automatic defibrillator, who presents with permanent atrial fibrillation, and severe secondary mitral and tricuspid regurgitation, and learn more...

How to treat my patient with combined mitral and tricuspid valve disease

When complications storm through the cathlab: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

What does the interventionist need to know from the imager?

21 Nov 2023 – From PCR London Valves 2023

Take inspiration from the discussions on the case of a 78-year-old patient with HTN, HLD, and AF, presenting with symptomatic heart failure, or that of a 59-year-old female patient, former smoker, with HTN, DM, and persistent AF, who had been treated for breast carcinoma and post-chemotherapy...

What does the interventionist need to know from the imager?
Didn’t find what you were looking for?